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Reduced expression of the Indy (I’m Not Dead, Yet)
gene in D. melanogaster and its homolog in
C. elegans prolongs life span and in D. melanogaster
augments mitochondrial biogenesis in a manner
akin to caloric restriction. However, the cellular
mechanism by which Indy does this is unknown.
Here, we report on the knockout mouse model of
the mammalian Indy (mIndy) homolog, SLC13A5.
Deletion of mIndy in mice (mINDY/ mice) reduces
hepatocellular ATP/ADP ratio, activates hepatic
AMPK, induces PGC-1a, inhibits ACC-2, and reduces
SREBP-1c levels. This signaling network promotes
hepatic mitochondrial biogenesis, lipid oxidation,
and energy expenditure and attenuates hepatic de
novo lipogenesis. Together, these traits protect
mINDY/ mice from the adiposity and insulin resis-
tance that evolve with high-fat feeding and aging.
Our studies demonstrate a profound effect of mIndy
on mammalian energy metabolism and suggest that
mINDYmight be a therapeutic target for the treatment
of obesity and type 2 diabetes.
INTRODUCTION
Energy balance and insulin action are both closely related to life
span.Whereascaloric excess leads toobesity, insulin resistance,
and increasedmortality, caloric restriction reduces adiposity and
increases lipid oxidation, insulin sensitivity, and mitochondrial184 Cell Metabolism 14, 184–195, August 3, 2011 ª2011 Elsevier Incbiogenesis. In addition, caloric restriction reverses obesity and
type 2 diabetes, delays aging, and prolongs life in many species,
includingprimates (Hursting et al., 2003; Lopez-Lluch et al., 2006;
Hunt et al., 2006; Fontana and Klein, 2007; Colman et al., 2009).
Mediators of the beneficial effects of caloric restriction include
decreased plasma concentrations of anabolic hormones and
growth factors, i.e., insulin and insulin-like growth factors
(Fontana and Klein, 2007). Reduced expression of the Indy (for
I’m Not Dead, Yet) gene in D. melanogaster and its homolog in
C. elegans has been shown to promote longevity in a manner
akin to caloric restriction; however, the cellular mechanism by
which reduced expression of Indy leads to increased survival is
unknown (Rogina et al., 2000; Fei et al., 2003, 2004; Wang
et al., 2009).
In D. melanogaster, Indy encodes a nonelectrogenic
dicarboxylate and citrate transporter (Knauf et al., 2002, 2006),
and it is mainly expressed in the fat body, midgut, and oenocyte
(Rogina et al., 2000), thus, in the major organs of intermediary
metabolism in flies. In mammals, the gene product of SLC13A5,
the sodium-coupled citrate transporter NaCT (mINDY),
shares the highest sequence and functional similarity with
D.melanogaster INDY (Inoueetal., 2002a), and it is predominantly
expressed in liver cells (Inoue et al., 2002b; Gopal et al., 2007).
In order to examine the effect that INDY might have on
energy metabolism and insulin sensitivity in mammals, we
created a knockout mouse model (mINDY/ mice) of the
mammalian Indy homolog SLC13A5 (mIndy) and assessed the
effect of mIndy deletion on energy homeostasis and energy
storage in vivo. Furthermore, we assessed the impact of mIndy
deletion on insulin action in young, chow-fed mice, as well as
after exposing them to two perturbations known to induce insulin
resistance, specifically, high-fat feeding and aging..
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Figure 1. mIndy Tissue Distribution and Functional Characteristics
(A andB)mINDY transport kinetics for citrate (A) and succinate (B). HEK293 cells were transfected with the plasmids pIndy-mouse.3.1 or empty expression vector
pcDNA3.1(+). Uptake assays were performed in HEK-mIndy cells and HEK-Co/418 cells transfected with the empty expression vector pcDNA3.1(+) serving as
control cells. Net uptake is expressed as the difference between the uptake of substrates into HEK-mIndy cells and HEK-Co/418 cells (n = 3–6 for each
concentration). Km values were determined by fitting the data to a nonlinear regression curve fit.
(C) mIndy mRNA tissue expression in mINDY+/+ and mINDY/ mice (n = 3–4).
(D) [14C]-citrate clearance in mINDY+/+ and mINDY/ mice in vivo (n = 6).
(E) Relative mINDY-substrate plasma concentrations. Plasma citrate concentration is increased in the mINDY/ mice, in which the cellular uptake of citrate is
reduced (n = 7–8), ***p < 0.01, all error bars represent SEM, see also Figures S1 and S2.
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Transport Kinetics of mINDY
cDNA encoding mINDY was cloned and stably transfected into
HEK293 cells. The uptake capacities of mINDY for the two
substrates with the highest plasma concentrations, namely
citrate and succinate, were analyzed. mINDY is a high-capacity
transporter for citrate at physiological concentrations (Km = 49 ±Cel9 mM, Vmax = 3760 ± 160 [pmol/(mg x min)]) (Figure 1A), and it
transports succinate with an intermediate capacity (Km = 105 ±
9 mM, Vmax = 443 ± 20 [pmol/(mg 3 min)]) (Figure 1B).
Generation ofmINDY–/– Mice
mINDY/ mice were generated as described in Figures S1A–
S1E (available online). We performed Southern blot analysis for
FloxP detection under stringent hybridization and washingl Metabolism 14, 184–195, August 3, 2011 ª2011 Elsevier Inc. 185
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Figure 2. mINDY Mice Characteristics
(A) Time course of body weight over a 9 month period (n = 9–15). Differences in
body weight increase with time.
(B) Representative photographs of mINDY+/+ and mINDY/ mice. Body
lengths of mINDY+/+ and mINDY/ mice are given in Figure S3. *p < 0.05,
#p < 0.01, all error bars represent SEM, see also Figure S3.
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mINDY and Mammalian Metabolismconditions. The results shown in Figure S1E clearly indicate that
the digests obtained with BamH1 gave one single band for wild-
type and KO/+ genomic DNA samples (3.5 kb), while the FloxP/+
genomic DNA samples showed the 3.5 kb band and a specific
band of 1.76 kb which correspond to the FloxP construction.
The litters produced when heterozygous (KO/+) mINDY mice
(mINDY+/) were bred contained the expected ratio of mIndy
wild-type (mINDY+/+), mINDY+/ mice, and homozygous mIndy
(mINDY/) pups, indicating no substantial embryonic lethality.
In wild-type mice, Indy mRNA expression was highest in liver
and low in white adipose tissue, brown adipose tissue, skeletal
muscle, small intestines, and the pancreas (Figure 1C), confirm-
ing previous mIndy expression levels in rodents (Gopal et al.,
2007) and humans (Nishimura and Naito, 2008). Liver mIndy
mRNA expression was completely abolished in the INDY/
mice and 50% reduced in heterozygous mINDY+/ mice
(Figure S1D). Functional significance of differences in mIndy
expression patterns in different organs and tissues was evalu-
ated by comparing the uptake of [14C]-citrate during an infusion
study in vivo in mINDY+/+ and mINDY/ mice. In line with the
highest expression of mIndy in liver, mINDY/ mice showed
a 20% reduction in hepatic citrate uptake (p = 0.03), without
significant differences in citrate uptake into skeletal muscle
and kidney (Figure 1D). [14C]-citrate uptake in primary hepato-
cytes from mINDY+/+ and mINDY/ mice indicated a reduced
citrate uptake by 36% into mINDY/ primary hepatocytes
(data not shown).
Expression of SLC13A3, encoding another hepatic plasma
membrane tri-/dicarboxylate transporter, was increased 3-fold
in the liver of regular chow-fedmINDY/mice,probablycompen-
sating formIndy loss. Thiscompensatory increasewascompletely
abolished when mice were fed a HFD (Figure S2).mIndy expres-
sion did not change significantly with high-fat feeding or aging
in mice (data not shown). In accordance with reduced cellular
citrate uptake, GC/MS plasma metabolite analysis revealed
increased relative plasma citrate concentrations in themINDY/
mice, a trend for increased malate concentrations, and no
changes in succinate and fumarate concentrations (Figure 1E).
Body Weight and Energy Expenditure
Compared to mINDY+/+ mice, body weights of mINDY+/ and
mINDY/ mice on a regular chow were 2% and 10% lower,
respectively, at 4 weeks of age (Figure 2A). mINDY/ mice
showed an increasing difference in body weight compared to
mINDY+/+ mice with time (Figures 2A and 2B). The relative
percentage of lean body mass and fat mass, as assessed by
1H-MRS, did not differ between genotypes up to an age of
3 months (Figure S3A). Body length ofmINDY+/ andmINDY/
mice at 3 months of age was 9.9 ± 0.2 cm and 9.9 ± 0.1 cm,
respectively, and 10.2 ± 0.1 cm in mINDY+/+ mice (Figure S3B).
Thus, loss of mIndy reduced overall growth. To determine the
reasons, mice were studied in metabolic cages. Oxygen
consumption (VO2), carbon dioxide production (VCO2), and
energy expenditure were increased in themINDY/mice (Table
S1). Because we observed a numerical increase in locomotor
activity in themINDY/mice, we also analyzed daytime energy
expenditure and locomotor activity separately, which is the time
when mice sleep and are typically inactive. During this time,
a significant increase in energy expenditure was still observed,186 Cell Metabolism 14, 184–195, August 3, 2011 ª2011 Elsevier Incwithout a numerical difference in locomotor activity (Figures
S4A–S4D) These data suggest that differences in locomotor
activity are likely due to a higher urge of the mINDY/ mice to
ingest their food, as evidenced by the sole increase in locomotor
activity during the first 3–4 hr of food ingestion (Figures S4A and
S4B). These data exclude locomotor activity as the main cause
of the increase in energy expenditure in the mINDY/ mice.
Protection from Nutritionally Induced Obesity
An increase in energy expenditure might limit weight gain on
a HFD. Thus, we studied the effect of 6 weeks of HFD (55%
Kcal from fat) on body weight and whole-body fat accumulation.
Body weight was reduced by 17% in the mINDY/ mice
compared to mINDY+/+ mice (Figure 3A), and the proportion of
fat mass to bodyweight wasmarkedly reduced (Figure 3B), while
lean body mass was increased in mINDY/ mice (Figure 3B).
Energy expenditure was also increased in the mINDY/ mice
(Table S1 and Figures S4A and S4B). Basal plasma b-hydroxy-
butyrate, a marker of hepatic lipid oxidation, was increased by
18% and by 62% in the mINDY+/ mice and the mINDY/
mice, respectively (Figure 3C). To further determine if this effect
is specific to liver tissue, we measured hepatic lipid oxidation.
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Figure 3. mINDY Mice Are Protected from HFD-
Induced Obesity
(A) Body weight of mINDY+/+, mINDY+/, and mINDY/
mice on a 6 week HFD (n = 8).
(B) Percent whole-body fat content and lean body mass
after a 6 week HFD in the indicated phenotype, as
assessed by 1Hmagnetic resonance spectroscopy (n = 8).
Body fat is reduced in HFD-fed mINDY/ mice.
(C) Plasma b-hydroxybutyrate, a marker of hepatic lipid
oxidation, is increased in HFD-fedmINDY/mice (n = 7).
(D) Lipid oxidation from [1-14C]oleate is increased in
primary hepatocytes of mINDY/ mice (n = 5).
(E) State III oxygen consumption in liver homogenate from
mINDY/ mice is increased (n = 3).
(F) Lipid synthesis from [14C]citrate is reduced by 90% in
mINDY/ primary hepatocytes (n = 6). *p < 0.05, #p < 0.01,
all error bars represent SEM, see also Figure S4.
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mINDY and Mammalian Metabolismin primary hepatocytes frommINDY/mice andmINDY+/+ mice
fed a HFD. PrimarymINDY/ hepatocytes showed an increased
proportion of lipid oxidation compared tomINDY+/+ hepatocytes
by 32% (Figure 3D). Fittingly, mINDY/ liver homogenate
showed an increase in oxygen consumption by 23% (Figure 3E).
Citrate can be converted to acetyl-CoA by ATP-citrate lyase and
used for lipid generation. Reduced lipogenesis could contribute
to reduced lipid accumulation. Consistent with this possibility,
we found that [14C]-citrate incorporation into intracellular sterols
and fatty acids was reduced by 90% in primary mINDY/
hepatocytes (Figure 3F). Together these data show that loss of
mIndy reduces hepatic lipid generation from external citrate
and induces hepatic lipid oxidation.
Protection from High-Fat Diet Induced
Hepatic Steatosis
Reduced proportions of fat mass due to increased hepatic lipid
oxidation potentially protect from ectopic hepatic lipid accumu-
lation induced by a high-fat diet (HFD). Indeed, liver lipid content
was markedly reduced in mINDY/ HFD-fed mice assessed
histologically in liver sections by H&E staining (Figure 4A, top),Cell Metabolism 14,oil red O staining (Figure 4A, middle) and elec-
tron microscopy (Figure 4A, bottom). Hepatic
triglyceride content was reduced by 20% in
mINDY/ mice compared to mINDY+/+ mice
(Figure 4B). We further analyzed hepatic lipid
metabolites using LC/MS-MS (Samuel et al.,
2004; Erion et al., 2009). Long-chain acyl-CoAs
did not differ, but hepatic diacylglycerol (DAG)
concentrations were reduced by 40% in
mINDY/ mice (Figure 4D), without a change
in hepatic ceramide content (Figure 4D). Hepatic
acyl-carnitines tended to be slightly higher in
the mINDY/ mice compared to the mINDY+/+
mice (mINDY/ mice, 671 ± 34 nmol/g liver-
tissue versus mINDY+/+, 607 ± 27 nmol/g liver-
tissue, p = 0.1). Ectopic DAG accumulation
has been proposed as a unifying hypothesis
for mediating the insulin resistance associated
with conditions such as high-fat feeding and
aging (DAG hypothesis) (Shulman, 2000; Erionand Shulman, 2010; Samuel et al., 2010). Accordingly, DAG
accumulation results from the imbalance between supply and
utilization of intracellular lipids. Increased DAG content in turn
results in activation of protein kinase Cs (nPKCs) and subse-
quent impairment in insulin signaling (Shulman, 2000; Samuel
et al., 2004, 2007, 2010; Erion and Shulman, 2010). In accor-
dance with the DAG hypothesis,mINDY/ had reduced hepatic
membrane PKC3 protein content (Figure 4C).
Protection from High-Fat Diet Induced Insulin
Resistance
According to the DAG hypothesis, DAG lipid species are major
mediators of insulin resistance through activation of nPKCs
(Shulman, 2000; Samuel et al., 2004, 2007, 2010; Erion and
Shulman, 2010). In order to assess the impact of mIndy loss on
glucose metabolism in vivo, intraperitoneal glucose tolerance
tests (IPGTTs) were performed. Basal plasma glucose and
insulin concentrations were decreased in mINDY/ mice
compared tomINDY+/+ mice (Table S2). The glycemic excursion
during the IPGTT was reduced by 20% (area under the curve),
and plasma insulin excursion was reduced by 47% (area under184–195, August 3, 2011 ª2011 Elsevier Inc. 187
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Figure 4. Protection from HFD-Induced Hepatic
Steatosis
(A) Representative H&E stains (top), oil red O stains
(middle), and electron microscopic magnifications of liver
samples from 6 week HFD-fed mice of the indicated
genotype; L, lipid droplets; M, mitochondria; N, nucleus.
(B) Liver triglyceride concentrations are reduced in the
mINDY/ mice after a 6 week HFD (n = 8).
(C) Hepatic membrane protein kinase 3 content is reduced
in mINDY/ mice (arbitrary units) (n = 4).
(D) Hepatic DAG and ceramide concentrations as as-
sessed by GC/MS/MS (n = 7–8); all error bars represent
SEM.
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mINDY and Mammalian Metabolismthe curve) in mINDY/ mice compared to mINDY+/+ mice
(Figures 5A and 5B). To discern tissue-specific contributions to
improved whole-body insulin sensitivity, hyperinsulinemic-
euglycemic (HE) clamps were performed (Figures 5C and 5D
and Table S3 [Ayala et al., 2010]). Consistent with the lower fast-
ing plasma glucose concentrations, basal endogenous glucose
production was reduced by 20% in mINDY/ mice (Figure 5E),
and endogenous glucose production during the HE clamp was
reduced by 50% in the mINDY/ mice compared to the
mINDY+/+ mice (Figure 5E), indicating improved hepatic insulin
responsiveness. In addition, peripheral glucose uptake (Fig-
ure 5F) by the gastrocnemius muscle (Figure 5G) was increased
by 38% in the mINDY/mice. This protection from fat-induced
muscle insulin resistance in mINDY/ mice was accompanied
by a 35% reduction in skeletal muscle DAG content (Figure 5H).
Reduced transport of citrate into cells could potentially result in
lower intracellular citrate concentrations and increased rates of
glycolysis (Randle et al., 1963). In order to test this possibility,
we measured plasma lactate concentrations and rates of
whole-body glycolysis and nonoxidative glucose metabolism188 Cell Metabolism 14, 184–195, August 3, 2011 ª2011 Elsevier Inc.(Tables S3A–S3C). Plasma lactate concentra-
tions were found to be lower by 20% in
mINDY/ mice compared to mINDY+/+ fed
a HFD (data not shown). Rates of glycolysis
were similar between mINDY+/+, mINDY+/,
andmINDY/mice, while rates of nonoxidative
glucose metabolism tended to be increased in
HFD-fed mINDY/ mice and were significantly
higher in older mINDY/ mice (Tables S3A–
S3C). Taken together, these data demonstrate
that increases in whole-body glycolytic flux are
not likely responsible for the increased insulin-
stimulated glucose uptake observed in the
mINDY/ mice.
Deletion ofmIndy Increases
Mitochondrial Metabolism via AMPK
Activation
Citrate infusion studies identified the liver as the
main organ of transport action for mINDY. In
order to determine the mechanism by which
loss of mIndy increases whole-body energy
metabolism, we first performed unbiasedmicro-
array analysis on hepatic tissue samples fromyoung mINDY+/+ and mINDY/ mice, without a difference in
body composition. Gene set enrichment analysis revealed
markedly increased expression of pathways regulating mito-
chondrial genes, oxidative phosphorylation (OXPHOS), and
electron transport chain (ETC) genes in themINDY/mice (Fig-
ure 6A). Consistent with findings in D. melanogaster (Wang et al.,
2009), mitochondrial density, assessed by the point counting
method using electron microscopy (Bergeron et al., 2001), was
increased in mINDY/ mice (Figures 6B and 6C), as were
multiple genes related to the ETC, TCA cycle, and OXPHOS
(Table S4). AMP-activated protein kinase (AMPK) is a metabolic
regulator that is activated by AMP and inhibited by ATP, which
promotes mitochondrial biogenesis, insulin sensitivity, and fat
oxidation (Bergeron et al., 2001). AMPK activity correlates tightly
with phosphorylation at Thr172-a subunit (phospho-AMPK).
Fasted mINDY/ mice exhibit a 52% reduction in hepatic ATP
content (Figure 6D), a 54% reduction in ATP/ADP ratio (Fig-
ure 6D), and a 62% increase in Thr172 phosphorylation of the
a subunit of AMPK (Figure 6E). In line with our observation that
skeletal muscle citrate uptake did not differ between mINDY+/+
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Figure 5. In Vivo Glucose Metabolism in mINDY Mice after a 6 Week
HFD
(A) Venous glucose concentrations during an IPGTT (1 mg/kg BW glucose)
in overnight fasted mice of the indicated genotype (n = 7–8).
(B) Venous insulin concentrations during the IPGTT (n = 7–8).
(C) Plasma glucose concentrations during HE clamp studies (n = 7–8).
(D) Glucose infusion rate during HE clamp studies is increased with deletion of
mIndy (n = 6–9).
(E) Endogenous glucose production in the basal and the clamped state
(n = 6–9).
(F) Peripheral glucose uptake during the HE clamp studies (n = 6–9).
(G) 14C-2-deoxyglucose uptake into gastrocnemius muscle during the HE
clamp is increased with deletion of mIndy (n = 5).
(H) Gastrocnemius muscle DAG content assessed by LC/MS/MS is reduced in
mINDY/mice (n = 5). *p < 0.05, #p < 0.01 by two-way ANOVA, all error bars
represent SEM, also see Table S3.
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mINDY and Mammalian MetabolismandmINDY/mice (Figure 1D), ATP content, AMPK activation,
and metabolic gene expression profiles did not differ in skeletal
muscle samples (Figures S5A and S5B).
Peroxisome proliferator-activated receptor-g coactivator
(PGC)-1a expression, a target of AMPK and a master regulator
of mitochondrial biogenesis (Lopez-Lluch et al., 2008), was
increased by 64% in liver of the mINDY/ mice (Figure 6F).CelAnother target of AMPK is acetyl-CoA carboxylase 2 (ACC-2)
(Ruderman et al., 1999). ACC-2 serine phosphorylation, which
reduces the activity of ACC-2, was also significantly increased
in the mINDY/ mice (Figure S5C). Next, we assessed other
genes that regulate hepatic lipid oxidation and synthesis
and found increased expression in genes that promote fat
oxidation in the mINDY/ mice in liver (Figure S5D), but not
skeletal muscle (Figures S5A and S5B). These data indicate
that liver is the main tissue of mIndy action. Protein content of
hepatic mature sterol regulatory element binding protein
(SREBP)-1c, a lipogenic master regulator, was decreased in
mINDY/ mice (Figure S5E). This decrease in mature SREBP-
1c can also explain the decrease in mitochondrial GPAT
(mtGPAT) mRNA expression (Figure S5D). In order to assess
a causal role of AMPK in mediating changes seen in mINDY/
mice, lipid synthesis from [14C]-citrate was measured with and
without the AMPK inhibitor Compound C in primary hepato-
cytes. Fatty acid synthesis could not be further increased in
mINDY+/+ hepatocytes, while AMPK inhibition increased lipid
synthesis in the mINDY/ hepatocytes by 240% (Figure S5F).
Taken together, these data indicate that AMPK activation is
at least in part responsible for the observed increases in
hepatic fatty acid oxidation and mitochondrial biogenesis as
well as for the decrease in hepatic lipogenesis in the mINDY/
mice.
Protection from Aging-Induced Adiposity and Insulin
Resistance
Reduced expression of Indy in D. melanogaster and C. elegans
increases life span (Rogina et al., 2000; Fei et al., 2004) and
reduces specific characteristics of aging in a manner akin to
caloric restriction (Wang et al., 2009). Since aging has been
shown to be associated with reduced mitochondrial function,
ectopic lipid accumulation, and muscle insulin resistance
(Petersen et al., 2003), we examined how loss of mIndy would
affect energy and glucose metabolism in older mice. We
observed that 8-month-old mINDY/ mice maintained on a
regular chow diet had a 17% reduction in body weight,
compared to age-matched littermatemINDY+/+ mice (Figure 7A),
together with a reduction in fat mass by 45% (Figure 7B) and
an increase in the proportion of lean body mass by 11% (Fig-
ure 7C). When comparing 3-month-old mINDY/ to 8-month-
old mINDY/ mice, proportions of fat mass and lean body
mass did not change, while in the 8-month-old mINDY+/+ mice,
fat mass increased (Figure 7B) and lean body mass decreased
significantly (Figure 7B). Similar to young mice, energy expendi-
ture was increased in the 8-month-old INDY/ mice compared
to 8-month-old INDY+/+ mice (Table S1).
Eight-month-old mINDY/mice and age-matched mINDY+/+
littermates were subjected to HE clamp studies. Basal glucose
and insulin concentrations were reduced by 16% and 29%,
respectively, in the older mINDY/ mice compared to older
mINDY+/+ mice (Table S2). Eight-month-old mINDY/ mice
showed preserved insulin sensitivity compared to 8-month-old
mINDY+/+ mice, as reflected by amarked increase in the glucose
infusion rate required to maintain euglycemia during the HE
clamp (Figure 7D and Table S3 [Ayala et al., 2010]). Endogenous
glucose production (Figure 7E, Table S3) during the HE clamp
was 2-fold lower in older mINDY/ mice compared to olderl Metabolism 14, 184–195, August 3, 2011 ª2011 Elsevier Inc. 189
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Figure 6. Loss of mIndy Enhances Mitochondrial Metabolism
(A) Hepatic gene set enrichment analysis in young mINDY/ mice compared to young mINDY+/+ mice on a regular chow (n = 4–5).
(B) Representative hepatic mitochondria (M) with similar EM magnification.
(C) Mitochondrial density (mitochondrial number/counted cell volume) as assessed by the point counting method by a sample-blinded specialist using electron
microscope magnification in liver slices of the indicated phenotype (n = 3).
(D) Hepatic ATP content (left) and ATP/ADP ratio assessed with 31P-MRS after a 24 hr fast are reduced in mINDY/ mice (n = 5).
(E) Representative immunoblots of hepatic AMP-activated protein kinase (AMPK) a Thr172 phosphorylation/total AMPK content (n = 6).
(F) Representative immunoblots of hepatic PGC-1a expression (n = 6), all error bars represent SEM, see also Figure S5.
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mINDY and Mammalian MetabolismmINDY+/+ mice, reflecting increased hepatic insulin responsive-
ness in the mINDY/ mice (Figure 7F). Whole-body glucose
metabolism during the HE clamp was increased by 68% in the
8-month-old mINDY/ mice (Figure 7G), which could be attrib-
uted to a 27% increase in skeletal muscle glucose transport
activity (Figure 7H) and a 43% increase in hepatic nonoxidative
glucose metabolism (Table S3).190 Cell Metabolism 14, 184–195, August 3, 2011 ª2011 Elsevier IncDeletion ofmIndy Mimics Various Transcriptional
Aspects of Calorie Restriction
Decreased Indy expression has been proposed to mimic a state
of caloric restriction in D. melanogaster (Wang et al., 2009;
Neretti et al., 2009). We performed unbiased whole-genome
microarray-based analysis of the transcriptional regulation
of pathways in mINDY/ mice versus mINDY+/+ mice and.
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Figure 7. Older mINDY–/– Mice Are Protected from
Adiposity and Insulin Resistance
(A) Body weight in 2-month-old (young) and 8-month-old mice
(old) of the indicated phenotype (n = 5–8).
(B) Proportion of whole body fat to body weight as assessed by 1H
magnetic resonance spectroscopy in 2-month-old (young) and
8-month-old mice (old) of the indicated phenotype (n = 5–8). The
percentage of whole-body fat did not change significantly in young
compared to old mINDY/ mice.
(C) Proportion of total lean bodymass as assessed by 1Hmagnetic
resonance spectroscopy in 2-month-old (young) and 8-month-old
mice (old) of the indicated genotype (n = 5–8).
(D) Glucose infusion rate during the HE clamp study in 3-month-
old (young) and 8-month-old (old) mice of the indicated genotype
(n = 5–8). OldermINDY/mice were protected from aging related
insulin resistance.
(E) Basal endogenous glucose production in 3-month-old (young)
and 8-month-old (old) mice of the indicated genotype (n = 6–7).
(F) Clamp endogenous glucose production in 3-month-old (young)
and 8-month-old (old) mice of the indicated genotype (n = 6–7).
(G) Peripheral glucose uptake during the HE clamp study in
3-month-old (young) and 8-month-old (old) mice of the indicated
genotype (n = 6–7).
(H) 14C-2-deoxyglucose uptake into gastrocnemius muscle during
the HE clamp studies in 8-month-old mINDY+/+ and mINDY/
mice (n = 6–7); all error bars represent SEM; ns, not significant.
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restricted mice versus ad libitum-fed mice. Eighty percent of
pathways were regulated in a similar fashion in mINDY/ and
calorically restricted mice (Figure S6A). Furthermore, calorie
restriction has been shown to reduce Indy mRNA expression
in D. melanogaster. We investigated whether similar results
would be observed after a prolonged fast in mice. Consistent
with these results, mIndy expression was reduced by 48% in
mice starved for 36 hr compared to fed mice (Figure S6B).
In order to assess the physiological impact of starvation on
mINDY/mice, we comparedmINDY+/+ andmINDY/ animals
that were fasted for 24 hr and 48 hr hours. mINDY/ mice
showed greater weight loss and markedly reduced glycogen
stores after 24 hr (Figures S7A and 7B), while plasma glucose
and insulin concentrations tended to be lower after 24 hr (Figures
S7C and S7D).Cell MetabolisDISCUSSION
Reduced expression of Indy and its homologs
increases life span in D. melanogaster and C. elegans
(Rogina et al., 2000; Fei et al., 2004). These findings
have been compared to caloric restriction (Wang
et al., 2009), an intervention that extends life span in
diverse species including mammals (Colman et al.,
2009; Fontana and Klein, 2007). Here, we show that
deletion of the mIndy homolog in mice reduces
adiposity, prevents lipid accumulation into liver and
skeletal muscle, and increases insulin sensitivity
under HFD conditions and during aging. Loss of
mIndy augments energy expenditure associated with
increased hepatic fat oxidation and attenuates hepatic
lipogenesis. Strikingly, caloric intake is not decreased
in mINDY/ mice.
Consistent with previous studies (Knauf et al., 2002, 2006), we
show that mINDY is a high-capacity plasma membrane trans-
porter for citrate (Km 49 ± 9 mM). Cytosolic citrate either origi-
nates from mitochondria, where it is generated in one turn of
the citric acid cycle for the ultimate conversion into ATP, or
citrate is taken up across the plasma membrane from the blood
stream, in which it circulates in relatively high concentrations
(50–150 mM) (Palmieri, 2004). Citrate is cleaved to oxaloacetate
and acetyl-CoA, which provides the immediate carbon source
for the biosynthesis of fatty acids, triacylglycerols, and choles-
terol (Muoio and Newgard, 2008). Fatty acids provide >70% of
the energy requirements of the liver (Alves et al., 2011). We
show that loss of mIndy reduces hepatocellular fatty acid and
sterol generation and promotes hepatic lipid oxidation and
thus reduces ectopic storage of fat in the liver. In line with this,
enhancing the function of the human mIndy gene productm 14, 184–195, August 3, 2011 ª2011 Elsevier Inc. 191
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mINDY and Mammalian Metabolismdose-dependently increases the cellular uptake of [14C]-citrate
as well as its incorporation into intracellular lipids (Inoue et al.,
2003).
Deletion ofmIndy induces a state of hepatic energy depletion,
as reflected by the decrease in hepatic ATP content and ATP/
ADP ratio. Increased AMP and decreased ATP concentrations
are major activators of AMPK (Zhang et al., 2009). Our data
suggest that reduced uptake of mINDY substrates leads to
depletion of biochemical energy, which results in the activation
of AMPK. Recent studies have shown that intracerebroventricu-
lar injection of citrate inhibits hypothalamic AMPK, which is
consistent with this possibility (Stoppa et al., 2008). AMPK
induces hepatic fatty acid oxidation through phosphorylation
and inhibition of ACC-2 activity, reduces lipid generation by
inhibition of SREBP-1c (Kahn et al., 2005), and promotes the
generation of ATP by inducing mitochondrial biogenesis through
activation of PGC-1a (Bergeron et al., 2001; Zhang et al., 2009).
The mIndy-deleted phenotype is consistent with these traits.
Moreover, cytosolic citrate acts as a turnstile in fuel sensing
and signaling, by allosteric activation of ACC-2 (Saha et al.,
1999; Ruderman et al., 1999), and it might inhibit glycolysis in
the presence of ATP (Bosca et al., 1985). Together, these data
indicate that citrate also acts as a signaling molecule and conse-
quently that reduced citrate signaling activity might contribute to
the mIndy-deleted phenotype. Yet our data do not completely
rule out the possibility that mINDY also exerts effects indepen-
dent of the uptake mechanism.
mIndy expression and activity are most abundant in liver and
much lower in other organs and tissues, but loss of mIndy not
only affected hepatic metabolism but also increased energy
expenditure, which in turn reduced whole-body fat content as
well as skeletal muscle lipid storage, and it increased insulin-
stimulated glucose uptake into skeletal muscle. These results
show similarities to liver-specific overexpression of AMPK
(Yang et al., 2008) in HFD-fed mice and other mouse models
with specifically targeted tissues and organs (Oyadomari et al.,
2008; Ahmadian et al., 2009; Dean et al., 2009). It is likely that
the relatively minor phenotype observed in the youngmINDY/
mice can also be attributed to the compensatory increase in
expression of SLC13A3 (NaDC3). With high-fat feeding, the
compensatory increase in SLC13A3 is abolished, and the meta-
bolic phenotype is fully developed.
Energy expenditure increases in response to water ingestion
through sympathetic nervous system activation (Boschmann
et al., 2007; Lechner et al., 2011). It is therefore possible that
augmented water drinking, as observed in the HFD-fed and older
mINDY/ mice, could have contributed to the observed
increase in energy expenditure. However, this event would not
explain the increase in energy expenditure in the young,
regular chow-fed mINDY/ mice that have a normal drinking
pattern.
Caloric restriction promotes mitochondrial biogenesis and
function (Hunt et al., 2006; Lopez-Lluch et al., 2008). Caloric
restriction is effective in correcting the unfavorable metabolic
consequences of high-fat feeding and aging (Fontana and Klein,
2007). We show that in calorically restricted mice, as compared
to isocalorically fed mice, 80% of transcriptionally regulated
pathways change in the same direction as in the mINDY/
mice. Functionally, loss of mIndy also mimics many aspects of192 Cell Metabolism 14, 184–195, August 3, 2011 ª2011 Elsevier Inccaloric restriction. Moreover, in flies and nematodes, both,
reduced expression of Indy and caloric restriction prolong life
span (Rogina et al., 2000; Fei et al., 2004), and AMPK has been
shown to be the mediator of longevity in response to most
dietary restriction regimens in C. elegans (Schulz et al., 2007;
Greer and Brunet, 2009; Mair et al., 2011). In addition, caloric
restriction does not increase life span further in flies with reduced
Indy expression (Toivonen et al., 2007; Wang et al., 2009),
pointing to similar underlying mechanisms in both conditions.
These data suggest that mIndy may be a key mediator of the
beneficial effects of dietary energy restriction. Since prolonged
caloric restriction is very difficult to achieve in humans, our
observations raise the tantalizing possibility that modulating
the levels or function of mIndy could lead to some of the
health-promoting effects of calorie restriction, without requiring
severe caloric restriction.
Hepatic lipid content is strongly associated with hepatic
insulin resistance (Samuel et al., 2010). A unifying hypothesis is
that insulin resistance in liver and skeletal muscle develops
when there is an imbalance between supply and utilization of
intracellular lipid, leading to net accumulation of intracellular
diacylglycerol (DAG hypothesis) (Shulman, 2000; Erion and
Shulman, 2010). In contrast, with aging, declines in mitochon-
drial function may contribute to net accumulation of intracellular
DAGs (Petersen et al., 2003; Reznick et al., 2007; Lee et al.,
2010). Consistent with this hypothesis, loss of mIndy reduces
hepatic DAG concentrations, decreases membrane PKC3
content, and protects from hepatic insulin resistance associated
with high-fat feeding and aging.
In summary, we show that the deletion of the mammalian
homolog of Drosophila Indy, protects mice from HFD-induced
and age-associated insulin resistance, which is at least in part
mediated by activation of AMPK with subsequent induction of
mitochondrial biogenesis via PGC-1a, increased hepatic lipid
oxidation, and energy expenditure, as well as reduced hepatic
lipid generation. Our data suggest that mIndy may be an attrac-
tive therapeutic target for the treatment of nonalcoholic fatty liver
disease, obesity, and type 2 diabetes.EXPERIMENTAL PROCEDURES
Generation of Mice
A detailed description is given in the Supplemental Experimental Procedures.Cloning of Mouse mINDY and Uptake Assays
Uptake assays were performed as described (Seithel et al., 2007). Briefly, the
cDNA encoding mouse mINDY was cloned using a PCR-based approach.
HEK293 cells were transfected with pIndy-mouse.3.1 using Effectene trans-
fection reagent (QIAGEN, Hilden, Germany). Uptake assays were performed
using HEK-mIndy cells, and HEK-Co/418 cells transfected with the empty
expression vector pcDNA3.1(+) serving as control cells. [1,5-14C]citric acid
and [1,4-14C]succinate (Hartmann Analytic, Germany) were dissolved in
uptake buffer, and unlabeled citric acid or succinate was added to the final
concentration mentioned. The cells were incubated with the uptake solution
for 10 min as described (Seithel et al., 2007). The intracellular accumulation
of radioactivity was detected by liquid scintillation counting (Perkin Elmer
Life Sciences). mINDY-mediated citric acid or succinate net uptake was
obtained by subtracting the uptake in vector-transfected HEK-Co/418 cells
from that in mINDY-expressing HEK cells. Km values were determined by
fitting the data to a nonlinear regression curve fit (Michaelis-Menten-fit [Prism
5, GraphPad Software, San Diego, CA])..
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Mice were housed under controlled temperature (22C ± 2C) and lighting
(12 hr of light, 0700–1900 hr; 12 hr of dark, 1900–0700 hr) with free access
to water and food. mINDY+/+, mINDY+/, and mINDY/ were fed a regular
chow diet (TD2018; Harlan Teklad, Madison,WI). DoughHFD (55% fat by calo-
ries; TD 93075; Harlan Teklad) was fed at the age of 5–6 weeks for a period of
6–8weeks in order to assess the effect of HFD onmetabolic regulation. Fat and
lean body masses were assessed by 1H-magnetic resonance spectroscopy
(Bruker BioSpin, Billerica, MA). Comprehensive animal metabolic monitoring
system (CLAMS; Columbus Instruments, Columbus, OH) was used to evaluate
activity, food consumption, and energy expenditure. Drinking was assessed
by a computed system counting consumed water droplets. More details are
given in the Supplemental Experimental Procedures.
Hyperinsulinemic-Euglycemic Clamp Studies and [14C] Citrate
Infusion Studies
HE clamp studies were conducted as described (Jurczak et al., 2011; Pajvani
et al., 2011). Details are given in the Supplemental Experimental Procedures.
Biochemical Analysis and Calculations
Calculations were done as described (Chutkow et al., 2010; Jornayvaz et al.,
2011), and details are given in the Supplemental Experimental Procedures.
mRNA Quantification by Real-Time PCR
Liver total RNA was isolated using the RNeasy kit per manufacturer’s instruc-
tions (Invitrogen Corporation, CA, USA), and qPCR was performed as
described (Lee et al., 2010). Primer sequences are displayed in Table S5.
Immunoblots
Immunoblots were performed as described (Zhang et al., 2010). Phospho-
AMPK and AMPK (Cell Signaling Technology, MA, USA), phospho-ACC2
and ACC2 (Santa Cruz Biotechnology Inc., CA, USA), PGC-1a (Cell Signaling
Technology, MA, USA), SREBP-1c (Santa Cruz Biotechnology Inc., CA, USA),
b-actin (Abcam, MA, USA), and Gapdh (Cell Signaling Technology, MA, USA)
were used as primary antibodies. PKC3 assays were performed as described
(Samuel et al., 2004).
Transmission Electron Microscopy Analysis
Individual liver samples were prepared as described (Bergeron et al., 2001).
Only cross-sections of liver were examined for quantification of mitochondrial
density. For each individual liver slice, six random pictures were taken at
a magnification of 7,1003 and printed at a final magnification of 18,2503.
The volume density of mitochondria was estimated using the point-counting
method (Bergeron et al., 2001) by a sample-blinded EM technician. The
average volume density was calculated for each individual mouse liver and
was used to calculate the average volume density for each genotype.
Lipid Oxidation and Lipid Synthesis in Primary Hepatocytes
Details are given in the Supplemental Experimental Procedures. Briefly,
primary hepatocytes were isolated at the Yale Liver Center. 106 cells per flask
were incubated in Williams E Medium with 0.1 mM [1-14C]oleate (Amersham
Biosciences, NJ, USA). After 1 hr, incubations were quenched with 20%
perchloric acid, and hyamine hydroxide was added to the filter paper in the
center well to collect [14CO2]. After 1 hr on ice, filter paper and perchloric
acid-soluble 14C-radioactivity were counted in a scintillation counter (New
et al., 1999). Reactions were normalized to protein amounts. Lipid synthesis
was assessed in cultures of isolated hepatocytes (106) with William E medium,
10 nM insulin, and 10 mM [1,5-14C]-citric acid (Movarek Biochemicals, CA,
USA) for 24 hr. Cells were homogenized in PBS and mixed with 10N NaOH
and ethanol. Sterols were extracted with hexanes twice. The lower layer, con-
taining sterols, was first mixed with 10M H2SO4 and then extracted with
hexanes. The upper layer was then dried and counted in a scintillation counter
to determine [14C]-fatty acids.
Oxygen Consumption in Liver Homogenate
Oxygen consumption was assessed with a Clark-type oxygen electrode (Han-
satech Instruments, UK) as described (Lee et al., 2010) with the exception that
liver homogenate was used.CelPlasma Metabolite Extraction, Measurement, Alignment,
and Normalization
Murine plasma (30ml) was extracted with 400 ml 100% methanol at 20C
(13C-sorbitol was added as an internal standard). After centrifugation, the
supernatant was vacuum dried. GC-TOF-MS metabolite profiling was per-
formed on a Leco Pegasus 3 time-of-flight mass spectrometer (Leco, St.
Joseph, MI, USA). The Direct Thermal Desorption injector (ATAS GL Interna-
tional, The Netherlands) was coupled to an HP 5890 gas chromatograph
and an autosampler with automatic derivatisation and linear exchange. This
eliminates the impact of potential degradation or synthesis artifacts and
sample carryover. During the derivatisation there was also added a retention
time index standard mixture. For detailed information, refer to Lisec et al.
(2006) and Catchpole et al. (2011). Chromatogram acquisition parameters
were those described previously (Weckwerth et al., 2004). The results were
exported from Leco Chroma TOF software (version 3.25) as cdf files. Peak
detection, retention time alignment, and library matching were performed
with the R-script ‘‘Target Search’’ (Cuadros-Inostroza et al., 2009). Relative
peak intensities were normalized by the median of 13C-sorbitol intensities of
all samples by the 13C-sorbitol intensity of the respective sample and log10
transformed.
ATP and ADP Content
Liver extracts were prepared for high field NMR analysis by homogenizing
100 mg of tissue in 0.9% perchloric acid (2 v/w) and ethanol (2v/w). After
homogenization, samples were centrifuged, and the supernatant was ex-
tracted and neutralized with K2CO3, lyophilized, and resuspended in buffer
containing 20 mM HEPES (pH 6), 20 mM EDTA, 0.5 M KCl, 50% D2O, and
1 mM phenylphosphonic acid (Sigma-Aldrich, St. Louis, MO). ATP and ADP
content was analyzed using a Bruker 5 mm 31P- NMR probe in an 11.7-T
vertical magnet. Spectra were acquired with TR = 1 s, NS = 2048, and 32K
data.
Microarray Analysis
Microarray data were analyzed using DIANE 6.0, a spreadsheet-based micro-
array analysis program based on SAS JMP7.0 system. All raw data are avail-
able in the GEO database. Details are given in the Supplemental Experimental
Procedures.
Statistical Analysis
A two-tailed Student’s t test was used to test differences between mINDY+/+
and mINDY/ mice. One-way ANOVA analysis was performed for multiple
comparisons, and two-way ANOVA was performed to test multiple time-
dependent effects. Values are presented asmean ±SEM; p < 0.05was consid-
ered statistically significant.
ACCESSION NUMBERS
Raw data were subjected to Z normalization and deposited in the Gene
Expression Omnibus (GEO) repository (accession number GSE29984 for
mINDY+/+ versus mINDY/ and GSE11845 for the CR mINDY+/+).
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, five tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.cmet.2011.06.009.
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